FDA Inspection 1207158 — Peyman Banooni, M.D.
The FDA completed an inspection of Peyman Banooni, M.D. on May 19, 2023 in Los Angeles, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 19, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Los Angeles, CA (United States)
Additional Details
Clinical Investigator (CI)